Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1994-11-30
1997-08-19
Weddington, Kevin E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514825, 514895, 514903, A61K 31445
Patent
active
056589492
ABSTRACT:
A novel method of inhibiting production of two important mediators of cellular function, tumor necrosis factor and nitric oxide, and treating a pathophysiological state characterized by an undesirable production or level of tumor necrosis factor or nitric acid. The methods of the present invention employ retinoic acid compounds. The most preferred retinoic acid is all-trans-retinoic acid. Also provided is a method of inhibiting tumor necrosis factor receptors using retinoic acid-like compounds.
REFERENCES:
patent: 5434173 (1995-07-01), Chandraratna
Chemical Abstracts 106:194429; Trinchieri et al. (1987).
Adler Benjamin Aaron
Research Development Foundation
Weddington Kevin E.
LandOfFree
Inhibition of tumor necrosis factor by retinoic acid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of tumor necrosis factor by retinoic acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of tumor necrosis factor by retinoic acid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1105263